Find information on thousands of medical conditions and prescription drugs.

Abciximab

Abciximab (previously known as c7E3 Fab), manufactured by Centocor and distributed by Eli Lilly under the trade name ReoPro®, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. Its mechanism of action is inhibition of glycoprotein IIb/IIIa. more...

Home
Diseases
Medicines
A
8-Hour Bayer
Abacavir
Abamectin
Abarelix
Abciximab
Abelcet
Abilify
Abreva
Acamprosate
Acarbose
Accolate
Accoleit
Accupril
Accurbron
Accure
Accuretic
Accutane
Acebutolol
Aceclidine
Acepromazine
Acesulfame
Acetaminophen
Acetazolamide
Acetohexamide
Acetohexamide
Acetylcholine chloride
Acetylcysteine
Acetyldigitoxin
Aciclovir
Acihexal
Acilac
Aciphex
Acitretin
Actifed
Actigall
Actiq
Actisite
Actonel
Actos
Acular
Acyclovir
Adalat
Adapalene
Adderall
Adefovir
Adrafinil
Adriamycin
Adriamycin
Advicor
Advil
Aerobid
Aerolate
Afrinol
Aggrenox
Agomelatine
Agrylin
Airomir
Alanine
Alavert
Albendazole
Alcaine
Alclometasone
Aldomet
Aldosterone
Alesse
Aleve
Alfenta
Alfentanil
Alfuzosin
Alimta
Alkeran
Alkeran
Allegra
Allopurinol
Alora
Alosetron
Alpidem
Alprazolam
Altace
Alteplase
Alvircept sudotox
Amantadine
Amaryl
Ambien
Ambisome
Amfetamine
Amicar
Amifostine
Amikacin
Amiloride
Amineptine
Aminocaproic acid
Aminoglutethimide
Aminophenazone
Aminophylline
Amiodarone
Amisulpride
Amitraz
Amitriptyline
Amlodipine
Amobarbital
Amohexal
Amoxapine
Amoxicillin
Amoxil
Amphetamine
Amphotec
Amphotericin B
Ampicillin
Anafranil
Anagrelide
Anakinra
Anaprox
Anastrozole
Ancef
Android
Anexsia
Aniracetam
Antabuse
Antitussive
Antivert
Apidra
Apresoline
Aquaphyllin
Aquaphyllin
Aranesp
Aranesp
Arava
Arestin
Arestin
Argatroban
Argatroban
Argatroban
Argatroban
Arginine
Arginine
Aricept
Aricept
Arimidex
Arimidex
Aripiprazole
Aripiprazole
Arixtra
Arixtra
Artane
Artane
Artemether
Artemether
Artemisinin
Artemisinin
Artesunate
Artesunate
Arthrotec
Arthrotec
Asacol
Ascorbic acid
Asmalix
Aspartame
Aspartic acid
Aspirin
Astemizole
Atacand
Atarax
Atehexal
Atenolol
Ativan
Atorvastatin
Atosiban
Atovaquone
Atridox
Atropine
Atrovent
Augmentin
Aureomycin
Avandia
Avapro
Avinza
Avizafone
Avobenzone
Avodart
Axid
Axotal
Azacitidine
Azahexal
Azathioprine
Azelaic acid
Azimilide
Azithromycin
Azlocillin
Azmacort
Aztreonam
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

While Abciximab has a short plasma half life, due to its strong affinity for its receptor on the platelets, it may occupy some receptors for weeks. In practice, platelet aggregation gradually returns to normal about 24 to 48 hours after discontinuation of the drug.

Abciximab is made from the Fab fragments of an immunoglobulin that targets the glycoprotein IIb/IIIa receptor on the platelet membrane.

Indications for use

Abciximab is indicated for use in individuals undergoing percutaneous coronary intervention (angioplasty with or without stent placement). The use of abciximab in this setting is associated with a decreased incidence of ischemic complications due to the procedure1 and a decreased need for repeated coronary artery revascularization in the first month following the procedure2.

Pharmacokinetics

Abciximab has a plasma half life of about ten minutes, with a second phase half life of about 30 minutes. However, its effects on platelet function can be seen for up to 48 hours after the infusion has been terminated, and low levels of glycoprotein IIb/IIIa receptor blockade are present for up to 15 days after the infusion is terminated.

Side effects

Many of the side effects of abciximab are due to its anti-platelet effects. This includes an increased risk of bleeding. The most common type of bleeding due to abciximab is gastrointestinal hemorrhage. Thrombocytopenia is a rare but known serious risk.

Read more at Wikipedia.org


[List your site here Free!]


Pulmonary hemorrhage after percutaneous coronary intervention with abciximab therapy : An article from: Mayo Clinic Proceedings $20.00 Abciximab improves stent outcomes in diabetics with MIs. (Admiral Study). : An article from: Internal Medicine News $5.95
Standard Heparin Challenged in MI Thrombolysis.(myocardial infarction ) : An article from: Internal Medicine News $5.95

Long-term survival benefit after use of abciximab? - Tips from Other Journals
Previous studies have shown the benefit of using intravenous platelet glycoprotein IIb/IIIa inhibitors (abciximab) during percutaneous coronary revascularization.
Stenting Plus Abciximab Reduces Damage After MI - Brief Article
Following myocardial infarction, one drawback of several reperfusion strategies is the potential to activate platelet and inflammatory mechanisms, which ...
Tirofiban vs. Abciximab for Platelet Inhibition
Use of platelet glycoprotein IIb/IIIa inhibitors has become more widespread in percutaneous coronary revascularization because of their demonstrated ...
Alveolar Hemorrhage as a Complication of Treatment With Abciximab - )
Study objective: The use of abciximab, a chimeric monoclonal antibody Fab fragment specific for platelet glycoprotein IIb/IIIa receptors, is associated ...
Abciximab and long-term protection from restenosis - Tips from Other Journals
Percutaneous coronary procedures are frequently followed by the need for repeat procedures or bypass surgery for coronary artery renarrowing. Abciximab ...
New drugs help angioplasty patients - abciximab, probucol - Biomedicine - Brief Article
Angioplasty, a procedure in which a tiny balloon is inserted into a blocked coronary artery and then inflated to open it, can make more invasive heart ...
Revascularization of left anterior descending coronary artery in patients with single and multivessel disease : comparison between off-pump internal thoracic
Study objectives: The left anterior descending artery (LADA), particularly when the proximal segment of the vessel is involved, is a challenging area ...
Future directions : American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac
The recommendations put forth in these guidelines for the management and prevention of atrial fibrillation (AF) after cardiac surgery are based on information ...

Home Contact Resources Exchange Links ebay